Gene · 4287
Papers3,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3'-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis. | PLoS Genet | 2024 | 38236804 | PubTator, text mining | PubMed |
| The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3. | Sci Rep | 2024 | 38233440 | PubTator, text mining | PubMed |
| Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3. | J Clin Invest | 2024 | 38227368 | PubTator, text mining | PubMed |
| Early-onset familial essential tremor is associated with nucleotide expansions of spinocerebellar ataxia in China. | Mol Biol Rep | 2024 | 38227102 | PubTator, text mining | PubMed |
| PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. | Breast Cancer Res | 2024 | 38217030 | PubTator, text mining | PubMed |
| A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease. | J Prim Care Community Health | 2024 | 38185870 | PubTator, text mining | PubMed |
| Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity. | Signal Transduct Target Ther | 2024 | 38177135 | PubTator, text mining | PubMed |
| The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias. | Cerebellum | 2024 | 38165578 | PubTator, text mining | PubMed |
| Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. | EBioMedicine | 2024 | 38150853 | PubTator, text mining | PubMed |
| NAGPKin: Nucleation-and-growth parameters from the kinetics of protein phase separation. | Mol Biol Cell | 2024 | 38117593 | PubTator, text mining | PubMed |
| Preoperative electroencephalographic alpha-power changes with eyes opening are associated with postoperative attention impairment and inattention-related delirium severity. | Br J Anaesth | 2024 | 38087743 | PubTator, text mining | PubMed |
| Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3. | Ann Neurol | 2024 | 37962377 | PubTator, text mining | PubMed |
| Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan. | Ann Clin Transl Neurol | 2024 | 37916889 | PubTator, text mining | PubMed |
| Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics. | Neural Regen Res | 2024 | 37862191 | PubTator, text mining | PubMed |
| Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan. | J Hum Genet | 2024 | 37848721 | PubTator, text mining | PubMed |
| Autophagy in neural stem cells and glia for brain health and diseases. | Neural Regen Res | 2024 | 37843206 | PubTator, text mining | PubMed |
| Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia. | J Neurol | 2024 | 37787810 | PubTator, text mining | PubMed |
| Dystonia and Parkinsonism in COA7-related disorders: expanding the phenotypic spectrum. | J Neurol | 2024 | 37750949 | PubTator, text mining | PubMed |
| Increased frequency of repeat expansion mutations across different populations. | medRxiv | 2024 | 37461547 | PubTator, text mining | PubMed |
| Genetic Epidemiology and Clinical Characteristics of Patients with Spinocerebellar Ataxias in an Unexplored Brazilian State, Using Strategies for Resource-Limited Settings. | Cerebellum | 2024 | 37454040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/papers?page=11